Nymox Pharmaceutical
NYMX
#8003
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-56.52%
Change (1 year)
Categories
Market capitalization of Nymox Pharmaceutical (NYMX)
Market cap: $18.25 Million
As of April 2024 Nymox Pharmaceutical has a market cap of $18.25 Million. This makes Nymox Pharmaceutical the world's 8003th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Nymox Pharmaceutical from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $18.25 M | 0% |
| 2023 | $18.25 M | -37.63% |
| 2022 | $29.26 M | -73.45% |
| 2021 | $0.11 B | -42.43% |
| 2020 | $0.19 B | 22.21% |
| 2019 | $0.15 B | 84.93% |
| 2018 | $84.72 M | -52.81% |
| 2017 | $0.17 B | 40.44% |
| 2016 | $0.12 B | -9.34% |
| 2015 | $0.14 B | 882.66% |
| 2014 | $14.34 M | -93.18% |
| 2013 | $0.21 B | -8.62% |
| 2012 | $0.23 B | -14.46% |
| 2011 | $0.26 B | 17.41% |
| 2010 | $0.22 B | 60.75% |
| 2009 | $0.14 B | 39.03% |
| 2008 | $0.10 B | -39.34% |
| 2007 | $0.16 B | 75.65% |
| 2006 | $96.29 M | 71.56% |
| 2005 | $56.13 M | -21.68% |
| 2004 | $71.66 M | -13.11% |
| 2003 | $82.47 M | 3.84% |
| 2002 | $79.42 M | -8.67% |
| 2001 | $86.96 M |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of Nymox Pharmaceutical was reported to be:
$18.1 Million
$18.25 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.11 B | 1,928,988.95% | 🇺🇸 USA |
 Pfizer PFE | $144.30 B | 790,507.88% | 🇺🇸 USA |
 Abbott Laboratories ABT | $186.15 B | 1,019,731.73% | 🇺🇸 USA |
 Eli Lilly LLY | $700.00 B | 3,834,889.54% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $15.00 B | 82,100.55% | 🇺🇸 USA |